Related Experiment Video
Updated: Jul 22, 2025
Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
Dynamic changes of oligodendrogenesis in neonatal rats with hypoxic-ischemic white matter injury
1Fujian Provincial Key Laboratory of Brain Aging and Neurodegenerative Diseases, Fujian Medical University, Fuzhou, China; Laboratory of Clinical Applied Anatomy, Department of Human Anatomy, School of Basic Medical Sciences, Fujian Medical University, Fuzhou, China.
Insights
Hypoxic-ischemic white matter injury (WMI) in neonatal rats disrupts oligodendrocyte development long-term. Promoting oligodendrocyte precursor cell (OPC) proliferation early may be key for treating preterm brain injury.
Area of Science:
- Neuroscience
- Developmental Biology
- Neonatal Research
Background:
- White matter injury (WMI) is a critical cause of preterm brain damage with limited treatment options.
- Oligodendrocyte vulnerability is central to WMI pathogenesis in preterm infants.
- Long-term effects of hypoxic-ischemic WMI on endogenous oligodendrogenesis remain unclear.
Purpose of the Study:
- To investigate the long-term dynamic changes in oligodendrogenesis following hypoxic-ischemic WMI in a neonatal rat model.
- To identify potential therapeutic targets for improving outcomes after preterm brain injury.
Main Methods:
- A hypoxic-ischemic WMI model was established in 3-day-old Sprague-Dawley rats.
- Immunofluorescence and Western blotting were employed to assess oligodendrogenesis markers over 84 days post-injury.
Main Results:
- In WMI rats, oligodendrocyte lineage cells were initially upregulated then downregulated, with OPC proliferation inhibited from day 3 to 14.
- Mature oligodendrocyte numbers decreased up to day 28, recovering by day 56, but myelin basic protein (MBP) expression remained low.
- Sham-operated rats showed a developmental peak in oligodendrocyte lineage from day 3 to 14.
Conclusions:
- Hypoxia-ischemia induces lasting alterations in neonatal brain white matter oligodendrogenesis.
- Early promotion of OPC proliferation (day 1) presents a potential therapeutic window.
- Simultaneous enhancement of oligodendrocyte maturation and function by day 28 is crucial for effective intervention.
Background:
White matter injury (WMI) is an important type of preterm brain injury, which may result in severe neurological sequelae and lack of effective treatments. It is ascertained that selective vulnerability of oligodendrocytes is closely related to the WMI in preterm infants. But the alteration of the endogenous oligodendrogenesis over long time after hypoxic-ischemic WMI is still not clearly elucidated.
Methods:
We adopted an animal model of hypoxic-ischemic WMI in 3-day-old neonatal Sprague-Dawley rats. Immunofluorescence staining and western blotting were used to detect dynamic changes of oligodendrogenesis in the white matter region on postoperative day (POD) 1, 3, 7, 14, 28, 56 and 84.
Results:
In the sham group, the oligodendrocyte lineage in the white matter reached a developmental peak from POD 3 to 14. The proliferation and development of oligodendrocyte precursor cells (OPCs) occurred primarily within POD 14. The number of mature oligodendrocytes showed an upward trend and a dynamic change in proliferation over time. While in the WMI group, the oligodendrocyte lineage was upregulated on POD1 and 3 but downregulated on POD 7 and 14. The proliferation of OPCs increased on POD 1 and decreased on POD 3 and 7, with the total number of OPCs significantly reduced from POD 3 to 14. The number of mature oligodendrocytes decreased from POD 3 to 28, and return to the level of the sham group on POD 56 and 84, whereas the MBP expression was still significantly downregulated on POD 56 and 84.
Conclusions:
Hypoxia-ischemia can have a long-term dynamic effect on the endogenous oligodendrogenesis of neonatal rat brain white matter. The proliferation of OPCs was promoted on POD 1 but inhibited from POD 3 to 14, which may be an early intervention target to improve oligodendrogenesis. The number of mature oligodendrocytes recover to the normal on POD 56 and 84 but the myelination is still blocked, which suggests it is essential to promote the maturation of oligodendrocyte and its function recovery at the same time within POD 28. Such efforts will provide the opportunity to test new interventions in pre-clinical studies for their promising clinical application.
